nodes	percent_of_prediction	percent_of_DWPC	metapath
Bleomycin—Radiation pneumonitis—Sorafenib—liver cancer	0.103	0.221	CcSEcCtD
Bleomycin—LIG3—Base Excision Repair—PCNA—liver cancer	0.0326	0.0611	CbGpPWpGaD
Bleomycin—Hyperkeratosis—Sorafenib—liver cancer	0.026	0.0557	CcSEcCtD
Bleomycin—LIG1—Mismatch repair—PCNA—liver cancer	0.023	0.0431	CbGpPWpGaD
Bleomycin—LIG1—Processive synthesis on the C-strand of the telomere—PCNA—liver cancer	0.0183	0.0343	CbGpPWpGaD
Bleomycin—LIG1—Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)—PCNA—liver cancer	0.0153	0.0287	CbGpPWpGaD
Bleomycin—LIG1—Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)—PCNA—liver cancer	0.0153	0.0287	CbGpPWpGaD
Bleomycin—LIG1—Homologous Recombination Repair—H2AFX—liver cancer	0.0148	0.0277	CbGpPWpGaD
Bleomycin—LIG1—Processive synthesis on the lagging strand—PCNA—liver cancer	0.0145	0.0272	CbGpPWpGaD
Bleomycin—LIG1—MMR—PCNA—liver cancer	0.0145	0.0272	CbGpPWpGaD
Bleomycin—LIG1—Removal of DNA patch containing abasic residue—PCNA—liver cancer	0.0138	0.0259	CbGpPWpGaD
Bleomycin—LIG1—Gap-filling DNA repair synthesis and ligation in GG-NER—PCNA—liver cancer	0.0138	0.0259	CbGpPWpGaD
Bleomycin—Cystitis haemorrhagic—Epirubicin—liver cancer	0.0137	0.0293	CcSEcCtD
Bleomycin—Mucosal inflammation—Sorafenib—liver cancer	0.0134	0.0287	CcSEcCtD
Bleomycin—Cystitis haemorrhagic—Doxorubicin—liver cancer	0.0127	0.0271	CcSEcCtD
Bleomycin—LIG1—Base Excision Repair—PCNA—liver cancer	0.0126	0.0237	CbGpPWpGaD
Bleomycin—LIG1—Lagging Strand Synthesis—PCNA—liver cancer	0.0117	0.0219	CbGpPWpGaD
Bleomycin—LIG1—Double-Strand Break Repair—H2AFX—liver cancer	0.0116	0.0217	CbGpPWpGaD
Bleomycin—LIG1—Telomere C-strand (Lagging Strand) Synthesis—PCNA—liver cancer	0.0108	0.0204	CbGpPWpGaD
Bleomycin—Interstitial lung disease—Sorafenib—liver cancer	0.0105	0.0225	CcSEcCtD
Bleomycin—LIG1—Extension of Telomeres—PCNA—liver cancer	0.00901	0.0169	CbGpPWpGaD
Bleomycin—LIG1—Extension of Telomeres—TERT—liver cancer	0.0087	0.0163	CbGpPWpGaD
Bleomycin—LIG3—DNA Repair—H2AFX—liver cancer	0.00836	0.0157	CbGpPWpGaD
Bleomycin—LIG1—DNA strand elongation—PCNA—liver cancer	0.00833	0.0156	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—CD81—liver cancer	0.00826	0.0155	CbGpPWpGaD
Bleomycin—LIG1—Global Genomic NER (GG-NER)—PCNA—liver cancer	0.00794	0.0149	CbGpPWpGaD
Bleomycin—LIG3—DNA Repair—PCNA—liver cancer	0.00783	0.0147	CbGpPWpGaD
Bleomycin—Skin exfoliation—Sorafenib—liver cancer	0.00709	0.0152	CcSEcCtD
Bleomycin—BLMH—Antigen processing: Ubiquitination & Proteasome degradation—PSMA4—liver cancer	0.00677	0.0127	CbGpPWpGaD
Bleomycin—BLMH—Antigen processing: Ubiquitination & Proteasome degradation—PSMD10—liver cancer	0.00677	0.0127	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—SRMS—liver cancer	0.00673	0.0126	CbGpPWpGaD
Bleomycin—LIG1—Transcription-coupled NER (TC-NER)—PCNA—liver cancer	0.00634	0.0119	CbGpPWpGaD
Bleomycin—Myelosuppression—Epirubicin—liver cancer	0.00586	0.0125	CcSEcCtD
Bleomycin—LIG1—Nucleotide Excision Repair—PCNA—liver cancer	0.00583	0.0109	CbGpPWpGaD
Bleomycin—BLMH—Class I MHC mediated antigen processing & presentation—PSMA4—liver cancer	0.00581	0.0109	CbGpPWpGaD
Bleomycin—BLMH—Class I MHC mediated antigen processing & presentation—PSMD10—liver cancer	0.00581	0.0109	CbGpPWpGaD
Bleomycin—LIG1—Synthesis of DNA—PSMA4—liver cancer	0.00547	0.0103	CbGpPWpGaD
Bleomycin—LIG1—Synthesis of DNA—PSMD10—liver cancer	0.00547	0.0103	CbGpPWpGaD
Bleomycin—Myelosuppression—Doxorubicin—liver cancer	0.00542	0.0116	CcSEcCtD
Bleomycin—LIG1—DNA Replication—PSMA4—liver cancer	0.00513	0.00962	CbGpPWpGaD
Bleomycin—LIG1—DNA Replication—PSMD10—liver cancer	0.00513	0.00962	CbGpPWpGaD
Bleomycin—BLMH—Immune System—CD81—liver cancer	0.00501	0.0094	CbGpPWpGaD
Bleomycin—Local reaction—Epirubicin—liver cancer	0.00496	0.0106	CcSEcCtD
Bleomycin—Mucosal inflammation—Epirubicin—liver cancer	0.00496	0.0106	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—FST—liver cancer	0.00464	0.00871	CbGpPWpGaD
Bleomycin—Skin hyperpigmentation—Epirubicin—liver cancer	0.00462	0.00989	CcSEcCtD
Bleomycin—Mucosal inflammation—Doxorubicin—liver cancer	0.00459	0.00983	CcSEcCtD
Bleomycin—Local reaction—Doxorubicin—liver cancer	0.00459	0.00983	CcSEcCtD
Bleomycin—Febrile neutropenia—Epirubicin—liver cancer	0.00456	0.00977	CcSEcCtD
Bleomycin—LIG1—S Phase—PSMD10—liver cancer	0.00449	0.00841	CbGpPWpGaD
Bleomycin—LIG1—S Phase—PSMA4—liver cancer	0.00449	0.00841	CbGpPWpGaD
Bleomycin—LIG1—Telomere Maintenance—H2AFX—liver cancer	0.00436	0.00818	CbGpPWpGaD
Bleomycin—Hypomagnesaemia—Epirubicin—liver cancer	0.00432	0.00926	CcSEcCtD
Bleomycin—Skin hyperpigmentation—Doxorubicin—liver cancer	0.00427	0.00915	CcSEcCtD
Bleomycin—Nail disorder—Epirubicin—liver cancer	0.00423	0.00907	CcSEcCtD
Bleomycin—Febrile neutropenia—Doxorubicin—liver cancer	0.00422	0.00904	CcSEcCtD
Bleomycin—Weight decreased—Sorafenib—liver cancer	0.00422	0.00903	CcSEcCtD
Bleomycin—Pneumonia—Sorafenib—liver cancer	0.00418	0.00895	CcSEcCtD
Bleomycin—Acute coronary syndrome—Sorafenib—liver cancer	0.0041	0.00877	CcSEcCtD
Bleomycin—LIG1—Telomere Maintenance—PCNA—liver cancer	0.00408	0.00766	CbGpPWpGaD
Bleomycin—BLMH—Immune System—SRMS—liver cancer	0.00408	0.00766	CbGpPWpGaD
Bleomycin—Myocardial infarction—Sorafenib—liver cancer	0.00407	0.00872	CcSEcCtD
Bleomycin—Stomatitis—Sorafenib—liver cancer	0.00405	0.00867	CcSEcCtD
Bleomycin—Hypomagnesaemia—Doxorubicin—liver cancer	0.004	0.00856	CcSEcCtD
Bleomycin—LIG1—Telomere Maintenance—TERT—liver cancer	0.00394	0.0074	CbGpPWpGaD
Bleomycin—Nail disorder—Doxorubicin—liver cancer	0.00392	0.00839	CcSEcCtD
Bleomycin—Haemoglobin—Sorafenib—liver cancer	0.00375	0.00803	CcSEcCtD
Bleomycin—Haemorrhage—Sorafenib—liver cancer	0.00373	0.00799	CcSEcCtD
Bleomycin—LIG1—Chromosome Maintenance—H2AFX—liver cancer	0.00363	0.00682	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—HNF4A—liver cancer	0.00361	0.00677	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—HPGDS—liver cancer	0.00354	0.00664	CbGpPWpGaD
Bleomycin—Hyperaesthesia—Epirubicin—liver cancer	0.0035	0.00749	CcSEcCtD
Bleomycin—Flushing—Sorafenib—liver cancer	0.00346	0.00741	CcSEcCtD
Bleomycin—LIG1—Synthesis of DNA—PCNA—liver cancer	0.00346	0.00649	CbGpPWpGaD
Bleomycin—LIG1—Chromosome Maintenance—PCNA—liver cancer	0.0034	0.00638	CbGpPWpGaD
Bleomycin—Alopecia—Sorafenib—liver cancer	0.0033	0.00706	CcSEcCtD
Bleomycin—LIG1—Chromosome Maintenance—TERT—liver cancer	0.00329	0.00617	CbGpPWpGaD
Bleomycin—Erythema—Sorafenib—liver cancer	0.00325	0.00695	CcSEcCtD
Bleomycin—LIG1—DNA Replication—PCNA—liver cancer	0.00324	0.00609	CbGpPWpGaD
Bleomycin—LIG1—DNA Repair—H2AFX—liver cancer	0.00324	0.00608	CbGpPWpGaD
Bleomycin—Hyperaesthesia—Doxorubicin—liver cancer	0.00324	0.00693	CcSEcCtD
Bleomycin—Extravasation—Epirubicin—liver cancer	0.00315	0.00674	CcSEcCtD
Bleomycin—LIG1—Disease—APCS—liver cancer	0.00312	0.00586	CbGpPWpGaD
Bleomycin—LIG1—DNA Repair—PCNA—liver cancer	0.00304	0.0057	CbGpPWpGaD
Bleomycin—Anaemia—Sorafenib—liver cancer	0.003	0.00643	CcSEcCtD
Bleomycin—Extravasation—Doxorubicin—liver cancer	0.00291	0.00624	CcSEcCtD
Bleomycin—Leukopenia—Sorafenib—liver cancer	0.00291	0.00623	CcSEcCtD
Bleomycin—Ulcer—Epirubicin—liver cancer	0.0029	0.00622	CcSEcCtD
Bleomycin—BLMH—Adaptive Immune System—PSMD10—liver cancer	0.00287	0.00539	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—PSMA4—liver cancer	0.00287	0.00539	CbGpPWpGaD
Bleomycin—LIG1—HIV Infection—PSMA4—liver cancer	0.00286	0.00536	CbGpPWpGaD
Bleomycin—LIG1—HIV Infection—PSMD10—liver cancer	0.00286	0.00536	CbGpPWpGaD
Bleomycin—LIG1—S Phase—PCNA—liver cancer	0.00284	0.00532	CbGpPWpGaD
Bleomycin—Cough—Sorafenib—liver cancer	0.00283	0.00607	CcSEcCtD
Bleomycin—Myalgia—Sorafenib—liver cancer	0.00277	0.00592	CcSEcCtD
Bleomycin—Ulcer—Doxorubicin—liver cancer	0.00269	0.00575	CcSEcCtD
Bleomycin—Cystitis noninfective—Epirubicin—liver cancer	0.00268	0.00574	CcSEcCtD
Bleomycin—Cystitis—Epirubicin—liver cancer	0.00265	0.00568	CcSEcCtD
Bleomycin—Anaphylactic shock—Sorafenib—liver cancer	0.00265	0.00568	CcSEcCtD
Bleomycin—Infection—Sorafenib—liver cancer	0.00263	0.00564	CcSEcCtD
Bleomycin—Skin exfoliation—Epirubicin—liver cancer	0.00262	0.00561	CcSEcCtD
Bleomycin—Thrombocytopenia—Sorafenib—liver cancer	0.0026	0.00556	CcSEcCtD
Bleomycin—Anorexia—Sorafenib—liver cancer	0.00253	0.00541	CcSEcCtD
Bleomycin—Bladder pain—Epirubicin—liver cancer	0.00248	0.00532	CcSEcCtD
Bleomycin—Cystitis noninfective—Doxorubicin—liver cancer	0.00248	0.00531	CcSEcCtD
Bleomycin—Cystitis—Doxorubicin—liver cancer	0.00245	0.00525	CcSEcCtD
Bleomycin—Skin exfoliation—Doxorubicin—liver cancer	0.00243	0.00519	CcSEcCtD
Bleomycin—Musculoskeletal discomfort—Sorafenib—liver cancer	0.00241	0.00517	CcSEcCtD
Bleomycin—Dyspnoea—Sorafenib—liver cancer	0.00236	0.00506	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—ABL1—liver cancer	0.00233	0.00436	CbGpPWpGaD
Bleomycin—Phlebitis—Epirubicin—liver cancer	0.00231	0.00495	CcSEcCtD
Bleomycin—Decreased appetite—Sorafenib—liver cancer	0.0023	0.00493	CcSEcCtD
Bleomycin—Bladder pain—Doxorubicin—liver cancer	0.0023	0.00492	CcSEcCtD
Bleomycin—Pain—Sorafenib—liver cancer	0.00227	0.00485	CcSEcCtD
Bleomycin—Phlebitis—Doxorubicin—liver cancer	0.00214	0.00458	CcSEcCtD
Bleomycin—Urticaria—Sorafenib—liver cancer	0.00211	0.00451	CcSEcCtD
Bleomycin—Body temperature increased—Sorafenib—liver cancer	0.0021	0.00449	CcSEcCtD
Bleomycin—Cerebrovascular accident—Epirubicin—liver cancer	0.00203	0.00436	CcSEcCtD
Bleomycin—LIG1—Synthesis of DNA—CDKN1B—liver cancer	0.00202	0.0038	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—PCNA—liver cancer	0.002	0.00374	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—CD8A—liver cancer	0.00197	0.00369	CbGpPWpGaD
Bleomycin—Hypersensitivity—Sorafenib—liver cancer	0.00195	0.00418	CcSEcCtD
Bleomycin—Asthenia—Sorafenib—liver cancer	0.0019	0.00407	CcSEcCtD
Bleomycin—LIG1—DNA Replication—CDKN1B—liver cancer	0.0019	0.00356	CbGpPWpGaD
Bleomycin—Cerebrovascular accident—Doxorubicin—liver cancer	0.00188	0.00403	CcSEcCtD
Bleomycin—Pruritus—Sorafenib—liver cancer	0.00188	0.00402	CcSEcCtD
Bleomycin—LIG1—Synthesis of DNA—CDKN1A—liver cancer	0.00187	0.0035	CbGpPWpGaD
Bleomycin—BLMH—Immune System—ADAM17—liver cancer	0.00185	0.00348	CbGpPWpGaD
Bleomycin—LIG1—DNA Replication—CDKN1A—liver cancer	0.00175	0.00329	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—MAPK14—liver cancer	0.00175	0.00328	CbGpPWpGaD
Bleomycin—BLMH—Immune System—PSMA4—liver cancer	0.00174	0.00327	CbGpPWpGaD
Bleomycin—BLMH—Immune System—PSMD10—liver cancer	0.00174	0.00327	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—ESR1—liver cancer	0.00172	0.00322	CbGpPWpGaD
Bleomycin—Vomiting—Sorafenib—liver cancer	0.00169	0.00361	CcSEcCtD
Bleomycin—Rash—Sorafenib—liver cancer	0.00167	0.00358	CcSEcCtD
Bleomycin—Dermatitis—Sorafenib—liver cancer	0.00167	0.00358	CcSEcCtD
Bleomycin—LIG1—S Phase—CDKN1B—liver cancer	0.00166	0.00311	CbGpPWpGaD
Bleomycin—Pancytopenia—Epirubicin—liver cancer	0.00164	0.0035	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—APC—liver cancer	0.00162	0.00305	CbGpPWpGaD
Bleomycin—LIG1—S Phase—CCND1—liver cancer	0.00158	0.00297	CbGpPWpGaD
Bleomycin—Nausea—Sorafenib—liver cancer	0.00157	0.00337	CcSEcCtD
Bleomycin—Weight decreased—Epirubicin—liver cancer	0.00156	0.00334	CcSEcCtD
Bleomycin—Pneumonia—Epirubicin—liver cancer	0.00154	0.00331	CcSEcCtD
Bleomycin—LIG1—S Phase—CDKN1A—liver cancer	0.00153	0.00287	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle, Mitotic—PSMA4—liver cancer	0.00153	0.00286	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle, Mitotic—PSMD10—liver cancer	0.00153	0.00286	CbGpPWpGaD
Bleomycin—BLMH—Immune System—IFNA1—liver cancer	0.00153	0.00286	CbGpPWpGaD
Bleomycin—Pancytopenia—Doxorubicin—liver cancer	0.00151	0.00324	CcSEcCtD
Bleomycin—Stomatitis—Epirubicin—liver cancer	0.0015	0.00321	CcSEcCtD
Bleomycin—Haematuria—Epirubicin—liver cancer	0.00146	0.00314	CcSEcCtD
Bleomycin—Weight decreased—Doxorubicin—liver cancer	0.00144	0.00309	CcSEcCtD
Bleomycin—Pneumonia—Doxorubicin—liver cancer	0.00143	0.00306	CcSEcCtD
Bleomycin—Haemoglobin—Epirubicin—liver cancer	0.00139	0.00297	CcSEcCtD
Bleomycin—Stomatitis—Doxorubicin—liver cancer	0.00139	0.00297	CcSEcCtD
Bleomycin—Haemorrhage—Epirubicin—liver cancer	0.00138	0.00295	CcSEcCtD
Bleomycin—Hypoaesthesia—Epirubicin—liver cancer	0.00137	0.00294	CcSEcCtD
Bleomycin—LIG1—Cell Cycle—PSMD10—liver cancer	0.00137	0.00256	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle—PSMA4—liver cancer	0.00137	0.00256	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—CDH1—liver cancer	0.00136	0.00255	CbGpPWpGaD
Bleomycin—Haematuria—Doxorubicin—liver cancer	0.00136	0.0029	CcSEcCtD
Bleomycin—BLMH—Immune System—PRKCE—liver cancer	0.00135	0.00253	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—PIK3CD—liver cancer	0.0013	0.00244	CbGpPWpGaD
Bleomycin—BLMH—Immune System—ABL1—liver cancer	0.00128	0.00241	CbGpPWpGaD
Bleomycin—Haemoglobin—Doxorubicin—liver cancer	0.00128	0.00275	CcSEcCtD
Bleomycin—Flushing—Epirubicin—liver cancer	0.00128	0.00274	CcSEcCtD
Bleomycin—Haemorrhage—Doxorubicin—liver cancer	0.00128	0.00273	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—RAF1—liver cancer	0.00127	0.00239	CbGpPWpGaD
Bleomycin—LIG1—S Phase—MYC—liver cancer	0.00127	0.00238	CbGpPWpGaD
Bleomycin—Hypoaesthesia—Doxorubicin—liver cancer	0.00127	0.00272	CcSEcCtD
Bleomycin—Chills—Epirubicin—liver cancer	0.00124	0.00265	CcSEcCtD
Bleomycin—LIG1—Disease—LTF—liver cancer	0.00122	0.00229	CbGpPWpGaD
Bleomycin—Alopecia—Epirubicin—liver cancer	0.00122	0.00261	CcSEcCtD
Bleomycin—BLMH—Immune System—HGF—liver cancer	0.00121	0.00227	CbGpPWpGaD
Bleomycin—Erythema—Epirubicin—liver cancer	0.0012	0.00257	CcSEcCtD
Bleomycin—BLMH—Immune System—CSF2—liver cancer	0.00119	0.00224	CbGpPWpGaD
Bleomycin—BLMH—Immune System—CD8A—liver cancer	0.00119	0.00224	CbGpPWpGaD
Bleomycin—Flushing—Doxorubicin—liver cancer	0.00118	0.00254	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—CDKN1B—liver cancer	0.00117	0.00219	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—RAF1—liver cancer	0.00116	0.00218	CbGpPWpGaD
Bleomycin—Chills—Doxorubicin—liver cancer	0.00114	0.00245	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—CASP3—liver cancer	0.00114	0.00215	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—PIK3CB—liver cancer	0.00113	0.00213	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—MTOR—liver cancer	0.00113	0.00213	CbGpPWpGaD
Bleomycin—Alopecia—Doxorubicin—liver cancer	0.00113	0.00241	CcSEcCtD
Bleomycin—Ill-defined disorder—Epirubicin—liver cancer	0.00111	0.00238	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—CCND1—liver cancer	0.00111	0.00209	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—JUN—liver cancer	0.00111	0.00208	CbGpPWpGaD
Bleomycin—Erythema—Doxorubicin—liver cancer	0.00111	0.00238	CcSEcCtD
Bleomycin—Anaemia—Epirubicin—liver cancer	0.00111	0.00238	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—CTNNB1—liver cancer	0.0011	0.00207	CbGpPWpGaD
Bleomycin—Malaise—Epirubicin—liver cancer	0.00108	0.00232	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—CDKN1A—liver cancer	0.00108	0.00202	CbGpPWpGaD
Bleomycin—Leukopenia—Epirubicin—liver cancer	0.00107	0.0023	CcSEcCtD
Bleomycin—BLMH—Adaptive Immune System—CDKN1B—liver cancer	0.00106	0.002	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—MAPK8—liver cancer	0.00105	0.00197	CbGpPWpGaD
Bleomycin—Cough—Epirubicin—liver cancer	0.00105	0.00224	CcSEcCtD
Bleomycin—LIG1—Cell Cycle, Mitotic—H2AFX—liver cancer	0.00103	0.00194	CbGpPWpGaD
Bleomycin—Ill-defined disorder—Doxorubicin—liver cancer	0.00103	0.00221	CcSEcCtD
Bleomycin—Anaemia—Doxorubicin—liver cancer	0.00103	0.0022	CcSEcCtD
Bleomycin—BLMH—Immune System—BCL2L1—liver cancer	0.00102	0.00192	CbGpPWpGaD
Bleomycin—Myalgia—Epirubicin—liver cancer	0.00102	0.00219	CcSEcCtD
Bleomycin—Chest pain—Epirubicin—liver cancer	0.00102	0.00219	CcSEcCtD
Bleomycin—Discomfort—Epirubicin—liver cancer	0.00101	0.00216	CcSEcCtD
Bleomycin—Malaise—Doxorubicin—liver cancer	0.001	0.00214	CcSEcCtD
Bleomycin—Leukopenia—Doxorubicin—liver cancer	0.000994	0.00213	CcSEcCtD
Bleomycin—Confusional state—Epirubicin—liver cancer	0.000988	0.00212	CcSEcCtD
Bleomycin—BLMH—Adaptive Immune System—CDKN1A—liver cancer	0.000981	0.00184	CbGpPWpGaD
Bleomycin—Anaphylactic shock—Epirubicin—liver cancer	0.00098	0.0021	CcSEcCtD
Bleomycin—Oedema—Epirubicin—liver cancer	0.00098	0.0021	CcSEcCtD
Bleomycin—Infection—Epirubicin—liver cancer	0.000973	0.00208	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—VEGFA—liver cancer	0.000971	0.00182	CbGpPWpGaD
Bleomycin—Cough—Doxorubicin—liver cancer	0.000969	0.00208	CcSEcCtD
Bleomycin—BLMH—Immune System—MAPK14—liver cancer	0.000967	0.00181	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle, Mitotic—PCNA—liver cancer	0.000966	0.00181	CbGpPWpGaD
Bleomycin—Thrombocytopenia—Epirubicin—liver cancer	0.000959	0.00205	CcSEcCtD
Bleomycin—Chest pain—Doxorubicin—liver cancer	0.000946	0.00202	CcSEcCtD
Bleomycin—Myalgia—Doxorubicin—liver cancer	0.000946	0.00202	CcSEcCtD
Bleomycin—LIG1—Disease—ALDOB—liver cancer	0.000942	0.00177	CbGpPWpGaD
Bleomycin—Discomfort—Doxorubicin—liver cancer	0.000934	0.002	CcSEcCtD
Bleomycin—Anorexia—Epirubicin—liver cancer	0.000934	0.002	CcSEcCtD
Bleomycin—LIG1—Cell Cycle—H2AFX—liver cancer	0.000922	0.00173	CbGpPWpGaD
Bleomycin—Hypotension—Epirubicin—liver cancer	0.000915	0.00196	CcSEcCtD
Bleomycin—Confusional state—Doxorubicin—liver cancer	0.000914	0.00196	CcSEcCtD
Bleomycin—Oedema—Doxorubicin—liver cancer	0.000906	0.00194	CcSEcCtD
Bleomycin—Anaphylactic shock—Doxorubicin—liver cancer	0.000906	0.00194	CcSEcCtD
Bleomycin—Infection—Doxorubicin—liver cancer	0.0009	0.00193	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—MYC—liver cancer	0.000893	0.00168	CbGpPWpGaD
Bleomycin—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000892	0.00191	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—TGFB1—liver cancer	0.000891	0.00167	CbGpPWpGaD
Bleomycin—Thrombocytopenia—Doxorubicin—liver cancer	0.000887	0.0019	CcSEcCtD
Bleomycin—Paraesthesia—Epirubicin—liver cancer	0.00088	0.00188	CcSEcCtD
Bleomycin—Dyspnoea—Epirubicin—liver cancer	0.000873	0.00187	CcSEcCtD
Bleomycin—Anorexia—Doxorubicin—liver cancer	0.000864	0.00185	CcSEcCtD
Bleomycin—LIG1—Cell Cycle—PCNA—liver cancer	0.000864	0.00162	CbGpPWpGaD
Bleomycin—Decreased appetite—Epirubicin—liver cancer	0.000852	0.00182	CcSEcCtD
Bleomycin—Hypotension—Doxorubicin—liver cancer	0.000847	0.00181	CcSEcCtD
Bleomycin—Pain—Epirubicin—liver cancer	0.000838	0.00179	CcSEcCtD
Bleomycin—LIG1—Cell Cycle—TERT—liver cancer	0.000834	0.00156	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	0.000832	0.00156	CbGpPWpGaD
Bleomycin—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000826	0.00177	CcSEcCtD
Bleomycin—BLMH—Immune System—CDH1—liver cancer	0.000826	0.00155	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	0.000825	0.00155	CbGpPWpGaD
Bleomycin—Paraesthesia—Doxorubicin—liver cancer	0.000814	0.00174	CcSEcCtD
Bleomycin—Dyspnoea—Doxorubicin—liver cancer	0.000808	0.00173	CcSEcCtD
Bleomycin—Feeling abnormal—Epirubicin—liver cancer	0.000807	0.00173	CcSEcCtD
Bleomycin—BLMH—Immune System—PIK3CD—liver cancer	0.000789	0.00148	CbGpPWpGaD
Bleomycin—Decreased appetite—Doxorubicin—liver cancer	0.000788	0.00169	CcSEcCtD
Bleomycin—Urticaria—Epirubicin—liver cancer	0.000778	0.00167	CcSEcCtD
Bleomycin—Pain—Doxorubicin—liver cancer	0.000775	0.00166	CcSEcCtD
Bleomycin—Body temperature increased—Epirubicin—liver cancer	0.000774	0.00166	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	0.000758	0.00142	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—KRAS—liver cancer	0.000752	0.00141	CbGpPWpGaD
Bleomycin—Feeling abnormal—Doxorubicin—liver cancer	0.000747	0.0016	CcSEcCtD
Bleomycin—LIG1—Disease—ADAM17—liver cancer	0.000745	0.0014	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	0.000734	0.00138	CbGpPWpGaD
Bleomycin—Hypersensitivity—Epirubicin—liver cancer	0.000722	0.00155	CcSEcCtD
Bleomycin—Urticaria—Doxorubicin—liver cancer	0.00072	0.00154	CcSEcCtD
Bleomycin—Body temperature increased—Doxorubicin—liver cancer	0.000717	0.00153	CcSEcCtD
Bleomycin—BLMH—Immune System—RAF1—liver cancer	0.000704	0.00132	CbGpPWpGaD
Bleomycin—Asthenia—Epirubicin—liver cancer	0.000703	0.00151	CcSEcCtD
Bleomycin—LIG1—Disease—PSMA4—liver cancer	0.0007	0.00131	CbGpPWpGaD
Bleomycin—LIG1—Disease—PSMD10—liver cancer	0.0007	0.00131	CbGpPWpGaD
Bleomycin—Pruritus—Epirubicin—liver cancer	0.000693	0.00148	CcSEcCtD
Bleomycin—BLMH—Adaptive Immune System—PIK3CA—liver cancer	0.000691	0.0013	CbGpPWpGaD
Bleomycin—BLMH—Immune System—MTOR—liver cancer	0.000687	0.00129	CbGpPWpGaD
Bleomycin—BLMH—Immune System—PIK3CB—liver cancer	0.000687	0.00129	CbGpPWpGaD
Bleomycin—LIG1—Disease—GOT2—liver cancer	0.000681	0.00128	CbGpPWpGaD
Bleomycin—Hypersensitivity—Doxorubicin—liver cancer	0.000668	0.00143	CcSEcCtD
Bleomycin—Asthenia—Doxorubicin—liver cancer	0.00065	0.00139	CcSEcCtD
Bleomycin—BLMH—Immune System—CDKN1B—liver cancer	0.000645	0.00121	CbGpPWpGaD
Bleomycin—Pruritus—Doxorubicin—liver cancer	0.000641	0.00137	CcSEcCtD
Bleomycin—BLMH—Adaptive Immune System—HRAS—liver cancer	0.000639	0.0012	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle, Mitotic—CDKN2A—liver cancer	0.000638	0.0012	CbGpPWpGaD
Bleomycin—BLMH—Immune System—IL2—liver cancer	0.000631	0.00118	CbGpPWpGaD
Bleomycin—Vomiting—Epirubicin—liver cancer	0.000623	0.00133	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	0.000619	0.00116	CbGpPWpGaD
Bleomycin—Rash—Epirubicin—liver cancer	0.000618	0.00132	CcSEcCtD
Bleomycin—Dermatitis—Epirubicin—liver cancer	0.000617	0.00132	CcSEcCtD
Bleomycin—BLMH—Immune System—JUN—liver cancer	0.000614	0.00115	CbGpPWpGaD
Bleomycin—BLMH—Immune System—CTNNB1—liver cancer	0.000609	0.00114	CbGpPWpGaD
Bleomycin—BLMH—Immune System—CDKN1A—liver cancer	0.000595	0.00112	CbGpPWpGaD
Bleomycin—LIG1—Disease—GOT1—liver cancer	0.000588	0.0011	CbGpPWpGaD
Bleomycin—Nausea—Epirubicin—liver cancer	0.000582	0.00125	CcSEcCtD
Bleomycin—BLMH—Immune System—MAPK8—liver cancer	0.000581	0.00109	CbGpPWpGaD
Bleomycin—Vomiting—Doxorubicin—liver cancer	0.000576	0.00123	CcSEcCtD
Bleomycin—Rash—Doxorubicin—liver cancer	0.000571	0.00122	CcSEcCtD
Bleomycin—Dermatitis—Doxorubicin—liver cancer	0.000571	0.00122	CcSEcCtD
Bleomycin—LIG1—Cell Cycle—CDKN2A—liver cancer	0.000571	0.00107	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle, Mitotic—CDKN1B—liver cancer	0.000565	0.00106	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—AKT1—liver cancer	0.000564	0.00106	CbGpPWpGaD
Bleomycin—LIG1—Disease—PRKCE—liver cancer	0.000543	0.00102	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle, Mitotic—CCND1—liver cancer	0.000539	0.00101	CbGpPWpGaD
Bleomycin—Nausea—Doxorubicin—liver cancer	0.000538	0.00115	CcSEcCtD
Bleomycin—BLMH—Immune System—STAT3—liver cancer	0.000531	0.000997	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle, Mitotic—CDKN1A—liver cancer	0.000522	0.000978	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle—CDKN1B—liver cancer	0.000505	0.000948	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle—CCND1—liver cancer	0.000482	0.000904	CbGpPWpGaD
Bleomycin—LIG1—Disease—H2AFX—liver cancer	0.000473	0.000888	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle—CDKN1A—liver cancer	0.000466	0.000875	CbGpPWpGaD
Bleomycin—BLMH—Immune System—KRAS—liver cancer	0.000456	0.000856	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle, Mitotic—MYC—liver cancer	0.000432	0.000811	CbGpPWpGaD
Bleomycin—LIG1—Disease—MTHFR—liver cancer	0.000429	0.000805	CbGpPWpGaD
Bleomycin—LIG1—Disease—TERT—liver cancer	0.000428	0.000803	CbGpPWpGaD
Bleomycin—BLMH—Immune System—PIK3CA—liver cancer	0.000419	0.000786	CbGpPWpGaD
Bleomycin—BLMH—Immune System—HRAS—liver cancer	0.000388	0.000727	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle—MYC—liver cancer	0.000387	0.000725	CbGpPWpGaD
Bleomycin—BLMH—Immune System—IL6—liver cancer	0.000371	0.000696	CbGpPWpGaD
Bleomycin—LIG1—Disease—APC—liver cancer	0.00036	0.000676	CbGpPWpGaD
Bleomycin—BLMH—Immune System—AKT1—liver cancer	0.000342	0.000642	CbGpPWpGaD
Bleomycin—LIG1—Disease—BRAF—liver cancer	0.000339	0.000636	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle—TP53—liver cancer	0.000318	0.000596	CbGpPWpGaD
Bleomycin—LIG1—Disease—PIK3CD—liver cancer	0.000317	0.000595	CbGpPWpGaD
Bleomycin—LIG1—Disease—SERPINE1—liver cancer	0.000313	0.000588	CbGpPWpGaD
Bleomycin—LIG1—Disease—RAF1—liver cancer	0.000283	0.000531	CbGpPWpGaD
Bleomycin—LIG1—Disease—MTOR—liver cancer	0.000276	0.000518	CbGpPWpGaD
Bleomycin—LIG1—Disease—PIK3CB—liver cancer	0.000276	0.000518	CbGpPWpGaD
Bleomycin—LIG1—Disease—CDKN1B—liver cancer	0.000259	0.000486	CbGpPWpGaD
Bleomycin—LIG1—Disease—CTNNB1—liver cancer	0.000245	0.000459	CbGpPWpGaD
Bleomycin—LIG1—Disease—CDKN1A—liver cancer	0.000239	0.000449	CbGpPWpGaD
Bleomycin—LIG1—Disease—STAT3—liver cancer	0.000213	0.0004	CbGpPWpGaD
Bleomycin—LIG1—Disease—MYC—liver cancer	0.000198	0.000372	CbGpPWpGaD
Bleomycin—LIG1—Disease—TGFB1—liver cancer	0.000198	0.000371	CbGpPWpGaD
Bleomycin—LIG1—Disease—KRAS—liver cancer	0.000183	0.000344	CbGpPWpGaD
Bleomycin—LIG1—Disease—PIK3CA—liver cancer	0.000168	0.000316	CbGpPWpGaD
Bleomycin—LIG1—Disease—HRAS—liver cancer	0.000156	0.000292	CbGpPWpGaD
Bleomycin—LIG1—Disease—IL6—liver cancer	0.000149	0.00028	CbGpPWpGaD
Bleomycin—LIG1—Disease—AKT1—liver cancer	0.000138	0.000258	CbGpPWpGaD
